SK285148B6 - Použitie tripeptidu a/alebo jeho soli na výrobu lieku na liečenie stresu - Google Patents

Použitie tripeptidu a/alebo jeho soli na výrobu lieku na liečenie stresu Download PDF

Info

Publication number
SK285148B6
SK285148B6 SK436-2000A SK4362000A SK285148B6 SK 285148 B6 SK285148 B6 SK 285148B6 SK 4362000 A SK4362000 A SK 4362000A SK 285148 B6 SK285148 B6 SK 285148B6
Authority
SK
Slovakia
Prior art keywords
stress
group
tripeptide
pro
exposed
Prior art date
Application number
SK436-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK4362000A3 (en
Inventor
Akihoro Masuyama
Toshiaki Takano
Original Assignee
Calpis Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co., Ltd. filed Critical Calpis Co., Ltd.
Publication of SK4362000A3 publication Critical patent/SK4362000A3/sk
Publication of SK285148B6 publication Critical patent/SK285148B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
SK436-2000A 1997-09-26 1998-02-05 Použitie tripeptidu a/alebo jeho soli na výrobu lieku na liečenie stresu SK285148B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26242297A JP4727770B2 (ja) 1997-09-26 1997-09-26 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
PCT/JP1998/000480 WO1999016461A1 (fr) 1997-09-26 1998-02-05 Agents antistress et aliments fonctionnels

Publications (2)

Publication Number Publication Date
SK4362000A3 SK4362000A3 (en) 2001-03-12
SK285148B6 true SK285148B6 (sk) 2006-07-07

Family

ID=17375571

Family Applications (1)

Application Number Title Priority Date Filing Date
SK436-2000A SK285148B6 (sk) 1997-09-26 1998-02-05 Použitie tripeptidu a/alebo jeho soli na výrobu lieku na liečenie stresu

Country Status (23)

Country Link
US (1) US6410685B1 (uk)
EP (1) EP1018341B1 (uk)
JP (1) JP4727770B2 (uk)
KR (2) KR100383492B1 (uk)
CN (1) CN1198641C (uk)
AT (1) ATE264687T1 (uk)
AU (1) AU728565B2 (uk)
BG (1) BG64692B1 (uk)
BR (1) BR9813222A (uk)
CA (1) CA2303810C (uk)
CZ (1) CZ298848B6 (uk)
DE (1) DE69823369T2 (uk)
DK (1) DK1018341T3 (uk)
ES (1) ES2219868T3 (uk)
HU (1) HUP0004617A3 (uk)
ID (1) ID25635A (uk)
IN (1) IN190794B (uk)
PL (1) PL192873B1 (uk)
PT (1) PT1018341E (uk)
SK (1) SK285148B6 (uk)
TR (1) TR200000863T2 (uk)
TW (1) TWI231213B (uk)
WO (1) WO1999016461A1 (uk)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334627A (en) * 1999-03-12 2002-07-26 Horticulture & Food Res Inst A therapeutic composition containing a therapeutic agent such as an anthelmintic and an antistress agent such as metyrapone or a nitric oxide promoter for increasing efficacy of therapeutic agents and animal growth
FR2793257B1 (fr) * 1999-05-06 2001-07-27 Gervais Danone Sa Bacteries lactiques a proprietes anxiolytiques, et leurs utilisations
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
JP4633876B2 (ja) * 1999-11-11 2011-02-16 カルピス株式会社 トリペプチドの製造方法
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
DE10105040A1 (de) 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105038B4 (de) 2001-02-05 2005-07-07 Neurotell Ag Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
DE10105041A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
US20050256057A1 (en) 2002-06-04 2005-11-17 Luppo Edens Protein hydrolysate rich in tripeptides
US20050222263A1 (en) * 2002-09-18 2005-10-06 Ajinomoto Co., Inc. Compositions against stress-related diseases and methods for treating stress-related diseases
JPWO2004026296A1 (ja) * 2002-09-18 2006-01-12 味の素株式会社 抗ストレス性疾患組成物
TWI411441B (zh) * 2003-03-18 2013-10-11 Suntory Holdings Ltd 血管收縮素轉化酶抑制性肽類
WO2004098309A1 (en) * 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
US20080292750A1 (en) * 2004-03-19 2008-11-27 Camoina Nederland Holding B.V. Method of Preparing a Food Ingredient and Food Product Having Angiotensin-I-Converting Enzyme Inhibiting Properties and Products Thus Obtained
EA011865B1 (ru) * 2004-07-12 2009-06-30 ДСМ Ай Пи ЭССЕТС Б.В. Протеиновые гидролизаты, снижающие давление крови
AU2006217901B2 (en) * 2005-02-24 2011-09-29 Dsm Ip Assets B.V. Blood pressure lowering peptides from glycomacropeptide
KR20080040683A (ko) * 2005-07-26 2008-05-08 칼피스가부시키가이샤 발효유의 제조 방법 및 발효유 음식품
US20100166859A1 (en) * 2006-01-16 2010-07-01 Luppo Edens Novel nutraceutical compositions and use thereof
CN101443031A (zh) * 2006-05-15 2009-05-27 瓦利奥有限公司 治疗用肽的新应用
JP5394628B2 (ja) * 2007-02-09 2014-01-22 クロスフィールドバイオ株式会社 新規なラクトバチルス属微生物および乳酸菌製剤
WO2009062914A2 (en) * 2007-11-14 2009-05-22 Dsm Ip Assets B.V. Novel blood pressure lowering composition
JP5618395B2 (ja) * 2009-08-13 2014-11-05 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2011136932A (ja) * 2009-12-28 2011-07-14 Calpis Co Ltd 脳機能改善用組成物および脳機能を改善する方法
JP2010183918A (ja) * 2010-06-01 2010-08-26 Calpis Co Ltd トリペプチドの製造方法
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
JP2011102331A (ja) * 2011-02-17 2011-05-26 Calpis Co Ltd 尿中ドーパミン低下の予防及び軽減剤
JP5892687B2 (ja) 2011-07-07 2016-03-23 高砂香料工業株式会社 風味改善ペプチド
CN103204909B (zh) * 2013-04-17 2014-09-03 苏州凯祥生物科技有限公司 一种抗高血压活性肽vppipp
JP5853326B2 (ja) * 2013-12-24 2016-02-09 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
JP2014208702A (ja) * 2014-07-31 2014-11-06 カルピス株式会社 自律神経活動調節用組成物および自律神経を調節する方法
CN104725485B (zh) * 2014-11-19 2018-01-16 扬州大学 一种重组活性肽及其同步制备方法
WO2017057319A1 (ja) * 2015-09-30 2017-04-06 株式会社明治 乳酸菌スターターの調製方法及び発酵乳の製造方法
CN111909978B (zh) * 2020-07-10 2021-06-22 青岛农业大学 一种利用发酵法从玉米蛋白粉中定向制备富含lpp水解物的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189064A (en) * 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
ES2077021T3 (es) * 1989-02-16 1995-11-16 Sankyo Co Peptidos que tienen actividad inhibidora de renina, su preparacion y uso.
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
US5593967A (en) * 1990-08-31 1997-01-14 Warner-Lambert Company Cholecystokinin antagonists, their preparation and therapeutic use
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
US5639729A (en) * 1993-08-26 1997-06-17 Immunobiology Research Institute, Inc. Tripeptides useful in immune and CNS therapy
US5604198A (en) * 1994-05-12 1997-02-18 Poduslo; Joseph F. Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents
JPH08275752A (ja) * 1995-04-07 1996-10-22 Riken Vitamin Co Ltd ストレス改善食品
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤

Also Published As

Publication number Publication date
EP1018341B1 (en) 2004-04-21
CN1198641C (zh) 2005-04-27
DE69823369D1 (de) 2004-05-27
CN1279614A (zh) 2001-01-10
DK1018341T3 (da) 2004-07-26
KR20030005137A (ko) 2003-01-15
CA2303810C (en) 2007-03-27
JP4727770B2 (ja) 2011-07-20
ID25635A (id) 2000-10-19
PT1018341E (pt) 2004-08-31
ES2219868T3 (es) 2004-12-01
BG104381A (en) 2001-02-28
IN190794B (uk) 2003-08-23
BR9813222A (pt) 2000-08-29
DE69823369T2 (de) 2005-05-04
KR20010024277A (ko) 2001-03-26
KR100383492B1 (ko) 2003-05-12
SK4362000A3 (en) 2001-03-12
AU5780198A (en) 1999-04-23
US6410685B1 (en) 2002-06-25
CZ20001083A3 (cs) 2001-01-17
ATE264687T1 (de) 2004-05-15
CZ298848B6 (cs) 2008-02-27
EP1018341A4 (en) 2002-08-28
EP1018341A1 (en) 2000-07-12
JPH11100328A (ja) 1999-04-13
WO1999016461A1 (fr) 1999-04-08
HUP0004617A2 (hu) 2001-05-28
TWI231213B (en) 2005-04-21
PL339348A1 (en) 2000-12-18
AU728565B2 (en) 2001-01-11
TR200000863T2 (tr) 2000-11-21
PL192873B1 (pl) 2006-12-29
HUP0004617A3 (en) 2001-11-28
BG64692B1 (bg) 2005-12-30
CA2303810A1 (en) 1999-04-08
KR100379819B1 (ko) 2003-04-14

Similar Documents

Publication Publication Date Title
SK285148B6 (sk) Použitie tripeptidu a/alebo jeho soli na výrobu lieku na liečenie stresu
AU2009228250B2 (en) Leucine-rich peptide compositions and methods for isolation
US5854029A (en) Method for preparing antihypertensive agent
KR102432193B1 (ko) 유청단백 가수분해물을 유효성분으로 함유하는 근감소증의 개선, 예방 또는 치료용 조성물
TW201039839A (en) Composition for regulating antonomic nervous activity and method for regulating autonomic nervous
US20220330595A1 (en) Angiotensin-converting enzyme inhibitor, blood pressure-lowering agent, and beverages and food products
JP4718534B2 (ja) Ｆｉｓｃｈｅｒ比低下抑制剤
MXPA00002839A (en) Antistress agents and functional foods
US20220322700A1 (en) Composition for alleviating, preventing or treating sarcopenia, containing whey protein hydrolysate as active ingredient
JP2011102331A (ja) 尿中ドーパミン低下の予防及び軽減剤
JP2005239686A (ja) 脂肪燃焼促進組成物及び該組成物を含有する食品又は医薬品
RU2457852C2 (ru) Новое применение терапевтически эффективных пептидов
TW200902045A (en) Agents for preventing cardiac failure

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20130205